Healthcare / Medical Care FacilitiesBSE
$5100.60
-136.45 (-2.67%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $184.5M · quality 36.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$24.7B
P/E
34.6x
↑EV/EBITDA
18.4x
↑ROE
20.2%
↑Gross Margin
78.4%
↑Debt/Equity
0.94
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+20.8%
FCF CAGR
—
FCF margin
9.9%
FCF / Net income
0.67x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.70B · net income $701.0M · FCF $467.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.70B | $4.70B | $3.97B | $3.17B | $2.67B |
| Net Income | $701.0M | $701.0M | $546.5M | $463.6M | $369.2M |
| EBITDA | $1.51B | $1.51B | $1.24B | $959.6M | $763.8M |
| EPS | — | — | 116.28 | 98.64 | 78.55 |
| Gross Margin | 78.4% | 78.4% | 77.4% | 77.7% | 77.1% |
| Operating Margin | 21.0% | 21.0% | 19.9% | 20.9% | 21.2% |
| Net Margin | 14.9% | 14.9% | 13.8% | 14.6% | 13.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.94 | 0.94 | 1.59 | 1.71 | 2.05 |
| Current Ratio | 1.23 | 1.23 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $467.5M | $467.5M | $-93.0M | $184.5M | $-7.2M |
| Returns | |||||
| ROE | 20.2% | 20.2% | 26.1% | 29.5% | 32.6% |
| Valuation | |||||
| P/E | 34.65 | 34.65 | 35.63 | — | — |
| EV/EBITDA | 18.40 | 18.40 | 18.36 | — | — |
| P/B | 7.12 | 7.12 | 9.29 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 18.3% | 18.3% | 25.5% | 18.7% | — |
| EPS Growth | — | — | 17.9% | 25.6% | — |
| Dividend Yield | 0.1% | 0.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+15.4%
Start / end P/E
n/dx → n/dx
EPS bridge
116.28 → n/d
Residual
+15.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.